DD147048A5 - Verfahren zur herstellung pharmazeutischer zusammensetzungen - Google Patents

Verfahren zur herstellung pharmazeutischer zusammensetzungen Download PDF

Info

Publication number
DD147048A5
DD147048A5 DD79216691A DD21669179A DD147048A5 DD 147048 A5 DD147048 A5 DD 147048A5 DD 79216691 A DD79216691 A DD 79216691A DD 21669179 A DD21669179 A DD 21669179A DD 147048 A5 DD147048 A5 DD 147048A5
Authority
DD
German Democratic Republic
Prior art keywords
pharmaceutical compositions
active ingredient
preparation
compound
phenyl
Prior art date
Application number
DD79216691A
Other languages
German (de)
English (en)
Inventor
Michel Vincent
Georges Remond
Jacques Bure
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of DD147048A5 publication Critical patent/DD147048A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
DD79216691A 1978-11-03 1979-11-05 Verfahren zur herstellung pharmazeutischer zusammensetzungen DD147048A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
DD147048A5 true DD147048A5 (de) 1981-03-18

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
DD79216691A DD147048A5 (de) 1978-11-03 1979-11-05 Verfahren zur herstellung pharmazeutischer zusammensetzungen
DD79216684A DD151445A5 (de) 1978-11-03 1979-11-05 Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD79216684A DD151445A5 (de) 1978-11-03 1979-11-05 Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern

Country Status (27)

Country Link
US (2) US4285943A (fr)
JP (2) JPS5566510A (fr)
AR (2) AR223989A1 (fr)
AT (1) AT368483B (fr)
AU (1) AU527630B2 (fr)
BE (2) BE879786A (fr)
CA (2) CA1139763A (fr)
CH (2) CH647225A5 (fr)
DD (2) DD147048A5 (fr)
DE (2) DE2944294A1 (fr)
DK (2) DK461579A (fr)
EG (1) EG14114A (fr)
ES (1) ES485656A0 (fr)
FI (2) FI793445A7 (fr)
FR (1) FR2440353A1 (fr)
GB (2) GB2034587B (fr)
GR (2) GR68015B (fr)
IL (2) IL58620A (fr)
IT (2) IT7950715A0 (fr)
MA (2) MA18628A1 (fr)
NL (2) NL7908099A (fr)
NZ (2) NZ192021A (fr)
OA (2) OA06372A (fr)
PT (2) PT70407A (fr)
SE (2) SE7909105L (fr)
SU (1) SU925247A3 (fr)
ZA (2) ZA795871B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
HRP20170936T1 (hr) 2009-02-16 2017-09-22 Nogra Pharma Limited Alkilamido spojevi i njihova uporaba
WO2013117744A2 (fr) 2012-02-09 2013-08-15 Nogra Pharma Limited Méthodes de traitement de la fibrose
NZ631049A (en) 2012-04-18 2017-02-24 Nogra Pharma Ltd Methods of treating lactose intolerance
AU2020217884B2 (en) 2019-02-08 2025-02-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
SU884568A3 (ru) * 1977-10-07 1981-11-23 Сьянс Юньон Э Ко.,Сосьете Франсэз Де Решерш Медикаль(Фирма) Способ получени (арилалкил) алкановых кислот

Also Published As

Publication number Publication date
NZ192020A (en) 1982-12-21
MA18628A1 (fr) 1980-07-01
BE879787A (fr) 1980-04-30
CA1139763A (fr) 1983-01-18
GR69726B (fr) 1982-07-09
SU925247A3 (ru) 1982-04-30
CH641043A5 (fr) 1984-02-15
IL58620A (en) 1982-12-31
AU5241679A (en) 1980-05-08
GR68015B (fr) 1981-10-27
SE7909106L (sv) 1980-05-04
SE7909105L (sv) 1980-05-04
PT70407A (en) 1979-12-01
PT70408A (fr) 1979-12-01
DK461679A (da) 1980-05-04
FR2440353A1 (fr) 1980-05-30
OA06373A (fr) 1981-08-31
GB2034587B (en) 1983-02-09
AT368483B (de) 1982-10-11
GB2034587A (en) 1980-06-11
GB2038802A (en) 1980-07-30
GB2038802B (en) 1982-12-08
IL58621A0 (en) 1980-02-29
ZA795871B (en) 1980-10-29
FI793444A7 (fi) 1981-01-01
CA1142087A (fr) 1983-03-01
AR223989A1 (es) 1981-10-15
US4404215A (en) 1983-09-13
ES8101538A1 (es) 1980-12-16
ES485656A0 (es) 1980-12-16
MA18629A1 (fr) 1980-07-01
NL7908101A (nl) 1980-05-07
BE879786A (fr) 1980-04-30
IT7950715A0 (it) 1979-10-31
DE2944293A1 (de) 1980-05-08
ZA795870B (en) 1980-10-29
NZ192021A (en) 1982-09-07
AR223990A1 (es) 1981-10-15
JPS5566510A (en) 1980-05-20
DD151445A5 (de) 1981-10-21
US4285943A (en) 1981-08-25
AU527630B2 (en) 1983-03-17
IL58620A0 (en) 1980-02-29
OA06372A (fr) 1981-08-31
DE2944294A1 (de) 1980-05-08
NL7908099A (nl) 1980-05-07
FI793445A7 (fi) 1981-01-01
ATA701679A (de) 1982-02-15
EG14114A (en) 1983-03-31
IT7950714A0 (it) 1979-10-31
DK461579A (da) 1980-05-04
CH647225A5 (fr) 1985-01-15
JPS5566548A (en) 1980-05-20

Similar Documents

Publication Publication Date Title
EP0044801B1 (fr) Sels non hygroscopiques de l'acide 4-hydroxybutyrique, procédé pour leur préparation et leur utilisation pour la fabrication des agents pharmaceutiques
DE2203373C3 (de) Neue 2- [(2- Alkylbenzofuran-3-yl)-methyl] -A2 -imidazoline
DE60300011T2 (de) Perindoprilsalz und dieses enthaltende Arzneimittel
DE2557497C2 (de) Tryptophanderivate und therapeutische Zubereitung
CH638775A5 (de) Verfahren zur herstellung neuer 4-amino-4-arylcyclohexanonverbindungen.
EP0761650B1 (fr) Modification cristalline thermostable et supportant le stockage du N-méthyle-N-((1S)-1-phényle-2-((3S)-3-hydroxypyrrolidin-1-yl)-éthyle)-2,2-diphényle-acétamide et procédé pour sa préparation
DD147048A5 (de) Verfahren zur herstellung pharmazeutischer zusammensetzungen
DE2166355C2 (de) Verwendung von d,1-Sobrerol bei der Balsamtherapie der Atemwege
DE2348973C3 (de) 1 -(m-Trifluormethylphenyl)-4-propyIpiperazin-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2801478C2 (fr)
DE2625222B2 (de) 13-Dithiacyclopentan-2-ylidenmalonsäureester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE68905406T2 (de) Chinolin-verbindung.
DE2513136C3 (de) N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE2332733A1 (de) Psychotherapeutisch wirksame 2-aminothiazolabkoemmlinge und diese enthaltende arzneimittel
DE2251556B2 (de) a-(l-Chlor-2-naphthyloxy)-propionsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2428201A1 (de) Anthranilsaeurederivate, verfahren zu deren herstellung und diese derivate enthaltende arzneimittel
DE2934166A1 (de) 1,3-benzoxazin-2,4-dion-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2609574A1 (de) Monosubstituiertes piperazinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel
DE2535799A1 (de) Entzuendungshemmende und antirheumatisch wirkende verbindungen
DE2935329A1 (de) 1-methyl-piperidin-4-ol-ester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2316914C3 (de) 4-(p-Chlorphenoxyacetylamino) benzoesäurediäthylamino-äthylester-pchlorphenoxyisobutyrat Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
EP0498011A1 (fr) Sels de l'acide 2-(2,6-dichloroanilino)-phénylacétique procédé pour leur préparation et leur application comme préparation pharmaceutique pour utilisation topique
DE2307795C3 (de) 11 beta 17alpha, 21 Trihydroxy-6
DE3040737A1 (de) Salze der 5-fluor-2-methyl-1(p-(methylsulfinyl)-benzyliden)-inden-3-essigsaeure, vefahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen